Ginsenoside Rb3
APC-129
Ginsenoside Rb3
Cat. No.
APC-129
CAS No.
68406-26-8
MF
C53H90O22
MW
1079.2685
Ginsenoside Rb3 is extracted from steamed Panax ginseng C. A. Meyer. Ginsenoside Rb3 exhibits inhibitory effect on TNFα-induced NF-κB transcriptional activity in 293T cell lines. Ginsenoside Rb3 also inhibits the induction of COX-2 and iNOS mRNA.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
68406-26-8
MF
C53H90O22
MW
1079.2685
Specification
98%
Research Area
Anti-inflammatory, Hypoglycemic, Antioxidant,Antioxidant
Description
Ginsenoside Rb3 is extracted from steamed Panax ginseng C. A. Meyer. Ginsenoside Rb3 exhibits inhibitory effect on TNFα-induced NF-κB transcriptional activity in 293T cell lines. Ginsenoside Rb3 also inhibits the induction of COX-2 and iNOS mRNA. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Certificate of Analysis (COA), Specification Sheet, HPLC, 1HNMR, 13CNMR, IR, MS, Safety Data Sheet (SDS/MSDS) etc.
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat.
References
[1]. He F, et al. Antitumor effects of dammarane-type saponins from steamed Notoginseng. Pharmacogn Mag. 2014 Jul;10(39):314-7.
[2]. Zhu JR, et al. Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells. Acta Pharmacol Sin. 2010 Mar;31(3):273-80.
[3]. Huang G, et al. Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice. Sci Rep. 2017 Oct 2;7(1):12552.
[2]. Zhu JR, et al. Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells. Acta Pharmacol Sin. 2010 Mar;31(3):273-80.
[3]. Huang G, et al. Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice. Sci Rep. 2017 Oct 2;7(1):12552.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
APC-1828
Eritadenine
CAS No.: 23918-98-1
MF: C9H11N5O4
APC-1827
Isobutyrylshikonin
CAS No.:52438-12-7
MF:C20H22O6
APC-1823
SO1861 (C28 sugar-chain positional isomer)
CAS No.:N/A
MF:C83H129O46
APC-1822
Bromocriptine mesylate
CAS No.:22260-51-1
MF:C32H40BrN5O5.CH4O3S
APC-1821
Cephaeline hydrochloride
CAS No.:3738-70-3
MF:C28H38N2O4.ClH
APC-1820
8-Feruloylharpagide
CAS No.:221003-20-9
MF:C25H32O13
APC-1819
6''-O-(p-coumaroyl)procumbide
CAS No.:87686-76-8
MF:C24H28O12
APC-1818
6′′-O-(p-Coumaroyl)harpagide
CAS No.:133561-42-9
MF:C24H30O12
APC-1817
Falcarinol
CAS No.:21852-80-2
MF:C17H24O
APC-1816
Dehydrotomatine
CAS No.:157604-98-3
MF:C50H81NO21
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
